AutismTEAm_YANCT05938751
An Intervention to Promote Self-determination in Young Adults With Autism: the TEAm_YOUNG ADULTS Program
A study testing TEAm_YOUNG ADULTS program in people with Autism, run by University Ramon Llull at 2 sites in Spain.
Trial summary
The goal of this clinical trial is to test the benefits of a program to develop self-determination in young adults with autism. Being self-determined means acting or causing things to happen in your life. It involves deciding, acting and believing in one-self. Read more about this study
- Who is it for?
- Ages 17 to 30 years
- Conditions the study is for
- Autism
- What is being tested?
- TEAm_YOUNG ADULTS program
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 40 participants
- Where
- 2 sitesSpain
- Study dates
- 15 Oct 2020to 31 Jul 2022
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 17 to 30 years
- All sexes
- No healthy volunteers
- Child, Adult
Who may be able to join
- To have a diagnosis of autism spectrum disorder in accordance with the criteria of the Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-5), or of Asperger's syndrome, according to he DSM-IV
- To be between 17 and 30 years old.
- To have a verbal comprehension index higher than 70 in the Wechsler Adult Intelligence Scale-IV (WAIS-IV), to ensure a good comprehension of the program
Who cannot join
- Not having spoken language
- Having a condition that could significantly interfere in the group functioning, such as an acute psychotic disorder or challenging behavior
Trial locations and contacts
2 sites in 1 country.
Spain2 sites
Ramon Llull University. Faculty of Psychology, Sciences of Education and Sports Blanquerna
Barcelona, 08022
University of Barcelona
Barcelona, 08035
About this study
Official title: A Multicentric Mixed-methods Study About the Promotion of Self-determination in Young Adults With Autism: the TEAm_YOUNG ADULTS Program
The goal of this clinical trial is to test the benefits of a program to develop self-determination in young adults with autism. Being self-determined means acting or causing things to happen in your life. It involves deciding, acting and believing in one-self.
The main question this clinical trial aims to answer is: Is the program developed useful to improve self-determination of young adults with autism?
Read more
Participants will receive a group intervention to support the development of their self-determination-related skills during 20 sessions (1 session/week).
Researchers will compare the self-determination outcomes between the group that receives the intervention and another group that is in a waiting list (and will receive the intervention later) to see if the changes are due to the intervention.
Read the detailed description
This clinical trial employed a convergent mixed methods design. Quantitative and qualitative data were collected from the same participants and analyzed separately within a similar timeframe. The quantitative strand used self-reported and proxy-reported questionnaires to evaluate the impact of the TEAm_YOUNG ADULTS program on the self-determination of young adults with autism. The quantitative data was collected at baseline and at the completion of the program, after 5 months (20 sessions). In the qualitative strand, focus groups were used to explore changes in self-determination perceived by the participants that received the program and their acceptance of the intervention. The focus groups were conducted when finishing the group and after the self-reported questionnaires are answered. Proxy-reports were answered after the realization of the focus groups.
- Conditions
- Autism
- Being tested
- TEAm_YOUNG ADULTS program
- Keywords
- Self-determination, Intervention, Young adults, Mixed-methods
- Medical subject headings
- Autistic Disorder
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
TEAm_YOUNG ADULTS programBehavioural
The TEAm_YOUNG ADULTS program is an intervention to develop self-determination in young adults with autism. It consists of 20 1.5h weekly sessions. The intervention is conducted by two facilitators with expertise in autism and self-determination promotion. Groups are formed by 4 to 6 participants. The program can be applied online or in person. The first five sessions address specific characteristics and support needs of people with autism. The next ten sessions are focused on the development of self-determination. The last five sessions are focused on working with others and the closure of the group. The individual goals of every participant are considered in the beginning of the group and a weekly follow-up of goals is conducted.
| Study group | Role | What they receive |
|---|---|---|
| Intervention group | Experimental | Participants in this group received the TEAm_YOUNG ADULTS program, an intervention to promote and develop self-determination-related skills. Receives: Behavioral: TEAm_YOUNG ADULTS program |
| Waiting list group | No intervention | Participants in this group were on the waiting list. That means they had to wait until the intervention group received the intervention and post-test evaluation to receive the intervention. They could keep their intervention as usual during the whole study. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change from baseline Self-determination after 20 sessions (Quantitative measure: self-report)
Self-Determination Inventory: Student Report (SDI:SR). The Spanish adaptation was used.
It is a self-report measure that evaluates the three dimensions of self-determination based on Causal Agency Theory (volitional action, agentic action and action-control beliefs) as well as the total self-determination scores.
Measured: At baseline and after the completion of the intervention (20 weeks later)
Self-determination (Qualitative measure)
Focus groups to evaluate the changes after the completion of the intervention. Questions related to the three dimensions of self-determination will be asked (volitional action, agentic action and action-control beliefs) in accordance with the quantitative measures to allow a joint display of the results following a mixed methodology (quantitative and qualitative). The focus groups will only be conducted for the intervention groups.
Measured: After the completion of the intervention (20 weeks later)
Change from baseline Self-determination after 20 sessions (Quantitative measure: proxy-report)
AUTODDIS Scale. It is a proxy-report measure that evaluates the three dimensions of self-determination based on Causal Agency Theory (volitional action, agentic action and action-control beliefs) as well as the total self-determination scores. The internal consistency of these sections was excellent (between α = .948 to α = .962), as well as for the entire scale (α = .983), and there is also evidence of its validity.
Measured: At baseline and after the completion of the intervention (20 weeks later)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted10 Jul 2023
- Study start15 Oct 2020
- Primary completion31 Jul 2022
- Study completion31 Jul 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for AutismStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Participants were assigned to the experimental group (which received the intervention) or to the control group (in a waiting list to receive the intervention after the conclusion of the study)
- Masking
- None (open label)
- Enrolment
- 40 participants (actual)
Sponsor and investigators
- Lead sponsor
- University Ramon Llull
- Sponsor type
- University, hospital or other
- Collaborators
- Hospital de Mataró, Fundació Friends, University of Barcelona
- Responsible party
- Principal investigator, Clara Andrés Gárriz, University Ramon Llull
- Investigators
- Clara Andrés Gárriz, M.D., Principal investigator, University Ramon Llull
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05938751
- Sponsor's protocol ID
- FPCEE_TeamYoungAdults2020/2023
- Acronym
- TEAm_YA
- Status last verified
- Jul 2023
- First submitted
- 20 Jun 2023
- Last updated
- 10 Jul 2023
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Andres-Garriz C, Farriols Hernando N, Gomez Hinojosa AM, Pretel-Luque T, Fabregues S, Mumbardo-Adam C. Promoting Self-Determination in Young Adults with Autism: A Multicenter, Mixed Methods Study. J Autism Dev Disord. 2026 Jul;56(7):2651-2670. doi: 10.1007/s10803-025-06739-6. Epub 2025 Feb 15.
PubMed 39954217
Study at a glance
From the registry record, last updated by the sponsor on 10 Jul 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Multicentric Mixed-methods Study About the Promotion of Self-determination in Young Adults With Autism: the TEAm_YOUNG ADULTS Program
- ClinicalTrials.gov ID
- NCT05938751
- Acronym / sponsor ID
- TEAm_YA / FPCEE_TeamYoungAdults2020/2023
- Conditions
- Autism
- Keywords
- Self-determination, Intervention, Young adults, Mixed-methods
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 40 participants (actual)
- Lead sponsor
- University Ramon LlullUniversity, hospital or other
- Collaborators
- Hospital de Mataró, Fundació Friends, University of Barcelona
- Study start
- 15 Oct 2020 (actual)
- Primary completion
- 31 Jul 2022 (actual)
- Study completion
- 31 Jul 2022 (actual)
- First posted
- 10 Jul 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this clinical trial is to test the benefits of a program to develop self-determination in young adults with autism. Being self-determined means acting or causing things to happen in your life. It involves deciding, acting and believing in one-self.
The main question this clinical trial aims to answer is: Is the program developed useful to improve self-determination of young adults with autism?
Participants will receive a group intervention to support the development of their self-determination-related skills during 20 sessions (1 session/week).
Researchers will compare the self-determination outcomes between the group that receives the intervention and another group that is in a waiting list (and will receive the intervention later) to see if the changes are due to the intervention.
Detailed description
This clinical trial employed a convergent mixed methods design. Quantitative and qualitative data were collected from the same participants and analyzed separately within a similar timeframe. The quantitative strand used self-reported and proxy-reported questionnaires to evaluate the impact of the TEAm_YOUNG ADULTS program on the self-determination of young adults with autism. The quantitative data was collected at baseline and at the completion of the program, after 5 months (20 sessions). In the qualitative strand, focus groups were used to explore changes in self-determination perceived by the participants that received the program and their acceptance of the intervention. The focus groups were conducted when finishing the group and after the self-reported questionnaires are answered. Proxy-reports were answered after the realization of the focus groups.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- Participants were assigned to the experimental group (which received the intervention) or to the control group (in a waiting list to receive the intervention after the conclusion of the study)
| Arm | Type | Receives |
|---|---|---|
| Intervention group | Experimental | Behavioral: TEAm_YOUNG ADULTS programParticipants in this group received the TEAm_YOUNG ADULTS program, an intervention to promote and develop self-determination-related skills. |
| Waiting list group | No intervention | –Participants in this group were on the waiting list. That means they had to wait until the intervention group received the intervention and post-test evaluation to receive the intervention. They could keep their intervention as usual during the whole study. |
Who may qualify
- Ages
- 17 to 30 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult
Key inclusion criteria (3 listed)
- To have a diagnosis of autism spectrum disorder in accordance with the criteria of the Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-5), or of Asperger's syndrome, according to he DSM-IV
- To be between 17 and 30 years old.
- To have a verbal comprehension index higher than 70 in the Wechsler Adult Intelligence Scale-IV (WAIS-IV), to ensure a good comprehension of the program
Key exclusion criteria (2 listed)
- Not having spoken language
- Having a condition that could significantly interfere in the group functioning, such as an acute psychotic disorder or challenging behavior
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| TEAm_YOUNG ADULTS programThe TEAm_YOUNG ADULTS program is an intervention to develop self-determination in young adults with autism. It consists of 20 1.5h weekly sessions. The intervention is conducted by two facilitators with expertise in autism and self-determination promotion. Groups are formed by 4 to 6 participants. The program can be applied online or in person. The first five sessions address specific characteristics and support needs of people with autism. The next ten sessions are focused on the development of self-determination. The last five sessions are focused on working with others and the closure of the group. The individual goals of every participant are considered in the beginning of the group and a weekly follow-up of goals is conducted. | Behavioural | Intervention group |
Primary outcome
Change from baseline Self-determination after 20 sessions (Quantitative measure: self-report)
Time frame: At baseline and after the completion of the intervention (20 weeks later)
Self-Determination Inventory: Student Report (SDI:SR). The Spanish adaptation was used. It is a self-report measure that evaluates the three dimensions of self-determination based on Causal Agency Theory (volitional action, agentic action and action-control beliefs) as well as the total self-determination scores.
Self-determination (Qualitative measure)
Time frame: After the completion of the intervention (20 weeks later)
Focus groups to evaluate the changes after the completion of the intervention. Questions related to the three dimensions of self-determination will be asked (volitional action, agentic action and action-control beliefs) in accordance with the quantitative measures to allow a joint display of the results following a mixed methodology (quantitative and qualitative). The focus groups will only be conducted for the intervention groups.
Change from baseline Self-determination after 20 sessions (Quantitative measure: proxy-report)
Time frame: At baseline and after the completion of the intervention (20 weeks later)
AUTODDIS Scale. It is a proxy-report measure that evaluates the three dimensions of self-determination based on Causal Agency Theory (volitional action, agentic action and action-control beliefs) as well as the total self-determination scores. The internal consistency of these sections was excellent (between α = .948 to α = .962), as well as for the entire scale (α = .983), and there is also evidence of its validity.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 10 Jul 2023.
- Derived from this study: PubMed 39954217Andres-Garriz C, Farriols Hernando N, Gomez Hinojosa AM, Pretel-Luque T, Fabregues S, Mumbardo-Adam C. Promoting Self-Determination in Young Adults with Autism: A Multicenter, Mixed Methods Study. J Autism Dev Disord. 2026 Jul;56(7):2651-2670. doi: 10.1007/s10803-025-06739-6. Epub 2025 Feb 15.
- Individual participant dataSharing planned: No
Related trials for Autism
Not yet recruiting
Sensory-integration Therapy Verses Augumented Reality-based Training in ASD
Autism Spectrum Disorder
Recruiting
Neuroimaging Predictors of Improvement to Pivotal Response Treatment (PRT) in Young Children With Autism
Autism Spectrum Disorder, Autism
RecruitingPhase 2
A Study of Esomeprazole in Children With Autism
Autism, Autism Spectrum Disorder
Recruiting
A Center Based Early Intervention Program For Preschoolers With Developmental Disorders
Development Disorder, Child, Developmental Disability
Recruiting
Transcranial Magnetic Stimulation for Restricted and Repetitive Behavior in ASD
Autism Spectrum Disorder, Autism
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Clara Andrés Gárriz, M.D. principal investigator
University Ramon Llull
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing TEAm_YOUNG ADULTS program in people with Autism, run by University Ramon Llull at 2 sites in Spain.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 10 Jul 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change from baseline Self-determination after 20 sessions (Quantitative measure: self-report) (time frame: At baseline and after the completion of the intervention (20 weeks later)). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT05938751, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Jul 2023; AzTrials last refreshed its copy on 6 Nov 2026.